About our e-newsletters
- Free e-newsletters
- Mayo Clinic expertise
- We do not share your e-mail address
Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, recipes, blogs, questions and answers with Mayo Clinic experts and more. Our biweekly topic-specific e-newsletters also include blogs, questions and answers with Mayo Clinic experts, and other useful information that will help you manage your health.
Housecall Archives
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Complications
By Mayo Clinic staffBladder cancer often recurs. Because of this, bladder cancer survivors often undergo follow-up testing for years after successful treatment. What tests you'll undergo and how often will depend on your type of bladder cancer and your treatment, among other factors.
Ask your doctor to create a follow-up plan for you. In general, doctors recommend a screening exam of the inside of your urethra and bladder (cystoscopy) every three to six months for the first four years after bladder cancer treatment. Then you may undergo cystoscopy every year. Your doctor may recommend other tests at various intervals as well.
People with aggressive cancers may undergo more frequent screening. Those with less aggressive cancers may undergo screening tests less often.
- What you need to know about bladder cancer. National Cancer Institute. http://www.cancer.gov/cancertopics/wyntk/bladder/allpages. Accessed Feb. 17, 2010.
- Bladder cancer treatment (PDQ): Health professional version. National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/treatment/bladder/healthprofessional/allpages/print. Accessed Feb. 17, 2010.
- Smith DC, et al. Carcinoma of the bladder. In: Abeloff MD, et al. Abeloff's Clinical Oncology. 4th ed. Philadelphia, Pa.: Churchill Livingstone; 2008:1635.
- Bladder and other urothelial cancers screening (PDQ): Health professional version. National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/screening/bladder/healthprofessional/allpages/print. Accessed Feb. 17, 2010.
- Bladder cancer. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/PDF/bladder.pdf. Accessed Feb. 17, 2010.
- Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1 and Tis): 2007 update. Linthicum, Md.: American Urological Association. http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=bc. Accessed Feb. 23, 2010.
- Messing EM. Urothelial tumors of the bladder. In: Wein AJ, et al. Campbell-Walsh Urology. Philadelphia, Pa.: Saunders Elsevier; 2007. http://www.mdconsult.com/das/book/body/185270227-3/0/1445/0.html. Accessed Feb. 23, 2010.
- La Rochelle J, et al. Chemoprevention of bladder cancer. BJU International. 2008;102:1274.
- Boehrn K, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database of Systematic Reviews. 2009:CD005004.
- Busby JE, et al. Chemoprevention for bladder cancer. The Journal of Urology. 2006;176:1914.
- Castle EP (expert opinion). Mayo Clinic, Scottsdale/Phoenix, Ariz. March 7, 2010.
Find Mayo Clinic on